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To evaluate incidence rates (IRs) of classic Kaposi’s sarcoma (CKS) in Italy after the spread of AIDS, we distinguished CKS from AIDS-
related KS (AKS) using an ‘ad hoc’ record linkage procedure between 15 Cancer Registries (CRs) (21% of the Italian population) and
the national AIDS Registry. Between 1985 and 1998, 874 cases of CKS and 634 cases of AKS were diagnosed in the study areas. CKS
accounted for 16 and 27% of KS cases below 55 years of age in men and women, respectively, but for 91 and 100% of those above
age 55. The IRs for CKS were 1.0/ in men and 0.4/100000 in women, but they varied between 0.3 in Umbria and 4.7 in Sassari in
men, and between 0.1 in Parma and 1.7 in Sassari in women. IRs of CKS in both genders were stable between 1985–1987 and
1993–1998. In Northern and Central CRs the IR (adjusted for age and gender) for CKS was 0.5 in individuals born in the same area,
but 1.6 in individuals born in Southern Italy or in the Islands (rate ratio¼3.2) suggesting that KS-associated herpesvirus, the cause of
KS, is acquired early in life.
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Before the AIDS epidemic, Kaposi’s sarcoma (KS) occurred
sporadically in Europe, most notably in elderly men of Mediterra-
nean or Middle Eastern origin (classic KS, CKS) (Franceschi and
Geddes, 1995). Some increase in incidence was reported in the
1960s and 1970s and attributed to the increase in immunosup-
pressive treatment (e.g. corticosteroid use) (Dictor and Attewell,
1988).
Since the 1980s, consequent on the AIDS epidemic, KS incidence
has increased in all Western countries (Dal Maso et al, 1999),
mainly due to the high frequency of AIDS-associated KS (AKS)
among HIV-infected homosexual and bisexual males (IARC, 1996).
KS-associated herpesvirus (KSHV or human herpesvirus type 8,
HHV8) is recognised as the necessary, though not sufficient, cause
of all clinical variants of KS (Moore and Chang, 1998; Iscovich et al,
2000).
Owing to the rise in AKS incidence, the evaluation of CKS
incidence trends has become difficult. KS rates in older persons
(e.g. X65 years), who have an extremely low prevalence of HIV/
AIDS, have been used as a proxy for CKS rates (Geddes et al, 1994;
Hjalgrim et al, 1998). Other studies manually reviewed medical
records of KS cases to distinguish major KS types (Ascoli et al,
2001; Santarelli et al, 2001). Automatic linkage procedures
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from AKS in populations where Cancer Registries (CRs) and HIV/
AIDS Registries both exist (Guttman-Yassky et al, 2003), and we
applied this approach in our Italian study.
MATERIALS AND METHODS
CKS and AKS were distinguished using the record-linkage
procedure of Cancer and AIDS Registries Linkage (CARL) study
(Dal Maso et al, 2003). Several independent CRs, covering a
population of 11.6 million (21% of the total Italian population),
have produced accurate KS incidence rates (IRs) for the mid-1990s
(Parkin et al, 2002; Zanetti et al, 2002). They covered the ‘North-
East network’, including the Friuli-Venezia Giulia region and the
provinces of Trento and Alto Adige, the regions of Romagna and
Umbria, part of the Veneto region, the municipality of Turin, the
provinces of Biella, Genoa, Varese, Parma, Modena, Ferrara,
Macerata, Florence and Prato, Sassari and Ragusa. CRs varied in
size, ranging from populations of approximately 190000 to 2
million, as well as in the number of registration years available
(Parkin et al, 2002; Dal Maso et al, 2003).
AIDS notification in Italy started in 1982 and has been
mandatory since 1986. By the end of the year 2000, 47503 AIDS
cases had been recorded according to the clinical standard
definitions (Istituto Superiore di Sanita `, 2003).
An ‘ad hoc’ software application (Software for Automated
Linkage in Italy, SALI) was developed to perform the record
linkage procedure (Dal Maso et al, 2001a). Briefly, records from
the Italian AIDS registry (RAIDS) and CRs are linked by first and
last name, and by date of birth. Satisfaction of the name-date
algorithm requires: (a) that the records are identical for at least one
critical field; and (b) that the other two critical fields, if not
identical, differ only in prescribed ways. Personal identifiers are
removed during linkage procedures; thus, the staff of each registry
is blinded to which persons have been linked. SALI has been
shown to have a very high sensitivity and specificity in the Italian
context, and it is available upon request (Dal Maso et al, 2001a).
The present study was restricted to people who: (1) were
diagnosed with KS between 1985 and 1998; (2) reported legal
residence in areas covered by CRs; and (3) had KS in periods
deemed complete by both CRs and RAIDS. All ages were included.
KS cases were considered AIDS-related when: (a) they occurred
in patients with AIDS notified at RAIDS; (b) AIDS was one of the
three causes mentioned on the death certificate; (c) HIV-infection
was mentioned in any additional medical record available at the
CR (e.g. HIV-positive test or mention of AIDS-related disease at
hospital admission or death). A total of 16 unlinked KS were
reclassified as AKS according to criteria (b) and (c), otherwise the
KS cases were considered as CKS.
Nine KS cases were excluded because they arose in the
transplant patients, information recorded in only three CRs
(Genoa, Sassari and Veneto). One KS case notified only by death
certificate and three for whom the type of diagnosis (e.g. clinical,
histological, etc) was unknown were also excluded.
Standardised IRs were computed by gender, place of residence,
place of birth and overall using the direct method (Breslow and
Day, 1987) and the 1991 Italian population as standard population.
Rate ratios (RR) adjusted by age and gender were calculated by
place of birth, and 95% percent confidence intervals (CI) were
computed according to the Poisson distribution (Breslow and Day,
1987). To evaluate temporal trends, IRs were computed separately
into three periods: (a) 1985–1987 (Parkin et al, 1992); (b) 1988–
1992 (Parkin et al, 1997) and (c) 1993–1998 (Parkin et al, 2002).
RESULTS
Between 1985 and 1998, 874 CKS and 634 AKS were reported to
Italian CRs (Table 1). The age distribution of CKS was similar for
men and women, the median age was 72 years (range 18–95), and
only 119 (14%) occurred in persons below age 55. Conversely, AKS
occurred at a median age of 36 (range 19–83) and only 49 (8%)
were diagnosed at age 55 or above.
With respect to site of cancer presentation, skin predominated
in both CKS (88%) and AKS (86%) but skin of the leg and hip was
more frequently involved in CKS than in AKS (Table 1). In total,
10% of AKS was diagnosed in the lip, oral cavity, pharynx and
digestive organs compared to only 3% of CKS.
Figure 1 shows the age-specific IRs of CKS and all KS in all
Italian study areas in the period 1985–1998. It is noteworthy that
in Italy CKS accounted for 91.0 and 100% of new cases of KS,
respectively, in men and women aged 55 years or older in Italy, but
only 15.7 and 26.9%, respectively, below that age. No significant
correlation emerged between IRs of CKS and AKS in different
areas (Spearman coefficient, r¼ 0.16 in men and 0.38 in women,
data not shown).
Table 2 shows CKS IRs by gender and place of residence.
Overall, the IRs were 0.98/100000 men and 0.41/100000 women.
However, a wide heterogeneity emerged, with IRs between 0.3 in
Umbria (Central Italy) to 4.7 in Sassari (Sardinia, Southern Italy)
in men, and between 0.1 in Parma (Northern Italy) to 1.7 in Sassari
Table 1 Observed (Obs) cases of classic and AIDS-related Kaposi’s sarcoma (KS) by site of presentation in 15 Italian Cancer Registries, 1985–1998
Classic KS AIDS-related KS
ICD 10; Site of presentation Obs (%)
a Obs (%)
a
C00–C14; lip, oral cavity and pharynx 9 (1.4) 29 (5.6)
C15–C26; digestive organs 9 (1.4) 20 (3.9)
C30–C39; respiratory and intrathoracic organs 5 (0.8) 2 (0.4)
C44; skin 551 (88.2) 444 (86.2)
C44.1–6; skin of face, scalp, neck, trunk, arm and shoulder 128 (23.2) 160 (36.0)
C44.7; skin of leg and hip 301 (54.6) 68 (15.3)
C44.8–9; skin, other or not specified 122 (22.2) 216 (48.6)
C49; connective, subcutaneous and other soft tissue 27 (4.3) 10 (1.9)
C51–C68; genital and urinary organs 15 (2.4) 5 (1.0)
Other and ill-defined sites 9 (1.4) 5 (1.0)
C80; unknown primary site 249 119
All sites 874 634
aUnknown primary site excluded from the calculation.
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Northern Italy, the IRs in Ferrara were similar to those in Ragusa
(Sicily) and significantly higher than those in nearby areas in both
genders. Three-fold higher IRs were found in the two CRs from
Southern Italy, mainly on account of particularly elevated IRs in
Sassari.
A high positive correlation (r¼0.66) between IRs in men and
women emerged. Thus, male-female ratios were generally between
2.0 and 2.5 in most of the areas, despite some probability of
random variation.
The association of place of birth and CKS was evaluated in
Northern and Central CRs (Table 3). Among CKS cases in
Northern and Central Italy, the IR was 0.5 for individuals born
in the same area, while it was 1.6 for individuals born in Southern
Italy or in the Islands (RR¼3.2; 95% CI: 3.2–3.3). The RRs for
individuals born in the South or in the Islands were particularly
elevated in the North-East (7.0) and Umbria (9.5), but close to unit
in Ferrara (1.7) and Varese (1.6).
Figure 2 shows trends in the CKS incidence and, for comparison
purposes, for all KS in the seven CRs that had been active since
1985. CKS IRs in men slightly increased between 1985–1987
(IR¼0.7) and 1988–1992 (1.0) but did not change thereafter (1.1
in 1993–1998). In women, the IRs were between 0.3 and 0.4
throughout the considered period. By contrast, consequent to the
steady increase of people with HIV/AIDS, the incidence of all KS
increased from 1.1 and 0.3 in 1985–1987 to 2.9 and 0.6 in 1993–
1998 in men and women, respectively.
DISCUSSION
Our study is one of the first attempts (Guttman-Yassky et al, 2003)
to describe the epidemiology of CKS in a large population after the
huge increase of KS caused by the AIDS epidemic (Dal Maso et al,
2001b). A many-fold higher incidence of CKS, compared to
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Figure 1 Incidence rates of classic Kaposi’s sarcoma (KS) and all KS by
age in 15 Italian Cancer Registries and burden of AIDS-related KS in men
and women, 1985–1998.
Table 2 Observed (Obs) cases, standardised incidence rates
a (IR), and 95% confidence intervals
b (CI) of classic Kaposi’s sarcoma by gender in 15 Italian
Cancer Registries, 1985–1998
Male Female
Cancer registry Obs IR (95% CI) Obs IR (95% CI)
North of Italy
Turin 86 1.22 (0.98–1.51) 35 0.43 (0.30–0.59)
Biella 2 0.44 (0.05–1.60) 5 0.90 (0.28–2.14)
Genoa 72 1.17 (0.91–1.48) 16 0.24 (0.14–0.39)
Varese 59 1.24 (0.94–1.60) 28 0.53 (0.35–0.76)
North East 28 0.66 (0.44–0.96) 16 0.32 (0.18–0.53)
Veneto 59 0.75 (0.57–0.97) 30 0.32 (0.21–0.45)
Parma 23 0.65 (0.41–0.97) 5 0.13 (0.04–0.30)
Modena 37 0.97 (0.68–1.33) 24 0.59 (0.38–0.88)
Ferrara 38 1.68 (1.18–2.31) 23 0.90 (0.57–1.36)
Romagna 38 0.70 (0.49–0.96) 26 0.44 (0.29–0.64)
Centre of Italy
Macerata 6 0.45 (0.16–0.98) 3 0.23 (0.04–0.70)
Florence 54 0.63 (0.47–0.83) 29 0.30 (0.20–0.44)
Umbria 5 0.26 (0.08–0.61) 4 0.18 (0.05–0.46)
Total, North and Centre 507 0.88 (0.81–0.96) 244 0.38 (0.33–0.43)
South of Italy
Sassari 60 4.69 (3.57–6.04) 20 1.65 (1.00–2.55)
Ragusa 28 1.47 (0.98–2.13) 15 0.92 (0.51–1.52)
Total, South 88 2.81 (2.25–3.46) 35 1.23 (0.85–1.71)
Total, Italy 595 0.98 (0.90–1.06) 279 0.41 (0.36–0.46)
aAge-standardised (per 100000 population) according to Italian population, 1991.
bComputed according to Poisson distribution.
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recorded in Italy before 1985 (Geddes et al, 1994; Franceschi and
Geddes, 1995; Cottoni et al, 1996).
A relatively high incidence of CKS was confirmed in the present
study for the 1985–1998 period and the evidence of a broad
within-country variation in both genders was expanded. The new
CR in Sardinia, one of the only two available in the South and
Islands, confirmed previous reports (Santarelli et al, 2001; Atzori
et al, 2004) and showed a four-fold excess, compared to North
(Ascoli et al, 2003) and Central Italy, where the majority of CRs are
concentrated. However, high rates of CKS are also recorded in
some areas in the North, notably in Ferrara, in the delta of the Po
(Parkin et al, 2002).
The reasons for such variations in CKS are not well understood.
In our present study, we showed that the incidence of CKS was
mainly determined by place of birth but not by the place of living.
Being born in the South of Italy was associated with a three-fold
increased risk of CKS among individuals who lived in the North
and Centre. The massive waves of migration from the rural South
to industrial towns in the North, such as Genoa, Turin and Varese
during the last century probably account for the moderate excess
of CKS in the corresponding CRs compared to the national
average.
Comparison with other countries is hampered by the difficulty
in distinguishing CKS and AKS. IRs for all KS, in the second
half of the 1990s, are available from 186 registries for 57 countries
(Parkin et al, 2002). These range, in men, from less than 0.5/
100000 in most CRs in Asia and Northern Europe, relatively
spared by the AIDS epidemic, to 16.7/100000 in non-Hispanic
Whites in San Francisco, California and 50.8/100000 in
Harare, Zimbabwe (Parkin et al, 2002). Apart from Italy,
recent population-based CKS IRs are only available for Israeli
Jews. After excluding AKS cases, Guttman-Yassky et al (2003)
reported for 1960–1998 a CKS incidence of 2.1/100000 for men
and 0.8/100000 for women, standardised using the world
standard population. Using the same standard population, the
IRs for Italy (0.6 in men and 0.2 in women) was lower
than in Israel, but in Sardinia (2.6 in men and 0.6 in women)
was similar to Israel. Substantial variations in the incidence of CKS
were shown in Israel by country of origin, with approximately two-
fold higher IRs among Jews from Iraq, Morocco, and Romania
compared to Jews who were born in Israel (Guttman-Yassky et al,
2003).
Our findings from Italy suggest substantial stability of CKS
incidence between 1985 and 1998, as in Israel in the same period,
when various Israeli subpopulations were taken into consideration
(Guttman-Yassky et al, 2003). A male-to-female ratio of 2-to-3 is
also similar in Italy and Israel.
Table 3 Observed (Obs) cases of classic Kaposi’s sarcoma, standardised incidence rates (IR)
a, rate ratio and 95% confidence intervals
b (CI) by place of
birth and place of residence among individuals of both genders in 12 Northern and Central Italian Cancer Registries
c, 1985–1998
Place of birth
South and Islands
d North and Centre
e
Place of residence Obs IR Obs IR Rate Ratio
f (95% CI)
North of Italy
Turin 85 2.08 34 0.37 5.6 (5.1–6.1)
Biella 0 0.00 7 0.78 0.0 –
Genoa 31 1.26 55 0.48 2.3 (2.0–2.5)
Varese 19 1.18 61 0.75 1.6 (1.4–1.8)
North East 12 2.66 29 0.38 7.0 (5.5–8.9)
Veneto 13 2.65 73 0.52 5.1 (4.3–6.2)
Parma 4 1.27 23 0.34 3.8 (2.0–7.0)
Modena 10 2.19 50 0.75 2.9 (2.2–3.9)
Ferrara 2 2.30 59 1.33 1.7 (0.6–4.9)
Romagna 6 1.82 56 0.53 3.4 (2.3–5.1)
Centre of Italy
Florence 25 1.00 54 0.31 3.2 (2.8–3.6)
Umbria 3 1.30 5 0.14 9.5 (3.2–28.0)
Total, North and Centre 210 1.56 506 0.48 3.2 (3.2–3.3)
aStandardised by age and gender (per 100000 population) according to Italian population, 1991.
bComputed according to Poisson distribution.
cInformation is not available for
Macerata Cancer Registry and is missing for 26 CKS cases.
dSouth and Islands includes Basilicata, Puglia, Campania, Calabria, Sicily and Sardinia.
eNorth and Centre includes Valle
d’Aosta, Piedmont, Liguria, Lombardy, Trentino-Alto Adige, Veneto, Friuli-Venezia Giulia, Emila-Romagna, Tuscany, Lazio, Umbria, Marche, Abruzzo and Molise.
fSouth and
Islands vs North and Centre.
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Figure 2 Age-standardised incidence rates (according to Italian popula-
tion, 1991) and 95% confidence intervals of classic Kaposi’s sarcoma (KS)
and all KS by year at diagnosis in seven Italian Cancer Registries (analyses
have been restricted to Cancer Registries active since 1985 (i.e., Turin,
Genoa, Varese, Parma, Romagna, Florence, and Ragusa), 1985–1998.
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KSHV antibodies in various geographic areas is correlated with the
frequency of KS not associated to AIDS. The seroprevalence of
KSHV antibodies is more than 25% in Africa and below 10% in the
United States and Europe (Whitby and Boshoff, 1998). Substantial
variations, consistent with those reported here for CKS incidence,
were also found between Italian regions, with seroprevalence below
10% in certain areas of the North (Calabro ` et al, 1998; Whitby et al,
1998) but higher than 30% in the Islands of Sicily and Sardinia
(Calabro ` et al, 1998; Perna et al, 2000; Santarelli et al, 2001;
Serraino et al, 2001).
Although sexual transmission is chiefly implicated in the high
prevalence of KSHV among homosexual and bisexual men (Moore
and Chang, 1998), other transmission routes have yet to be fully
elucidated. KSHV is shed in saliva, like other viruses of the Herpes
family (Wojcicki, 2003), and nonsexual transmission has been
suggested to be the major route of transmission in Africa, where
the infection is common in children (Mbulaiteye et al, 2003). Our
findings concerning the importance of birth place, independently
of place of residence, also suggest that in Italy early acquisition of
KSHV infection is, or was, common in the middle-aged or elderly
individuals with CKS in the present study. The excess of CKS in
some Italian areas where wetlands and swamps are widespread
(e.g. the Po delta, where Ferrara is located, and part of Sardinia)
may have different explanations (Ascoli et al, 2001). These include
a link between KS and malaria (Geddes et al, 1995) or, rather than
malaria itself, the high-density of particular haematophagous
insects (e.g. malaria vector Anopheles, black flies, sand flies, biting
midges and mosquitoes). The practice of applying saliva to
children’s bite sites to relieve the itching and scratching may
represent an efficient route of KSHV transmission (Coluzzi et al,
2003). Extensive land reclamation up to the 1960s and DDT-
spraying in the early 1950s in malaria-endemic areas of Italy
should have reduced this type of KSHV transmission (Coluzzi et al,
2003), but did not seem to have yet produced a decline of CKS, a
disease chiefly of the elderly. Genetically increased susceptibility to
KSHV infection and KS development in some Mediterranean
populations, including those from Southern Italy, is also a
possibility (Iscovich et al, 2000).
The significance of our findings depends on the accurate
distinction of CKS from other neoplasms and KS variants. The
majority (96%) of CKS reported here were histologically confirmed
and, therefore, misclassification with sarcomas other than KS or
with skin cancer can be ruled out. Misclassification of some AKS as
CKS is of greater concern but should not account for our findings.
AIDS registration in Italy is nationwide and has been shown to be
almost complete (Ajdaicic-Gross et al, 2001). Moreover, in Italy,
HIV-testing is routinely performed in patients with KS and CR
staff reviewed medical records of all CKS cases. In very few KS
(2%), not matched with RAIDS, HIV-positivity or history of
illnesses typically related to HIV or AIDS were found. Few cases of
KS would have arisen because of severe iatrogenic immune
suppression but, in the three CRs that systematically collected
details of organ transplantation, only 3% of KS unrelated to AIDS
had occurred in organ recipients.
In conclusion, between 1985 and 1998 in Italy, CKS accounted
for 97% of all KS in elderly people (X65 years) and a non-
negligible fraction (42%) of KS in men between 39 and 64 years.
Presently, there is no evidence that the improvements in the
standard of living in Italy over the last decades are causing a
decline in this disease. Separation of CKS from AKS will be
important in studies of the disease, especially now that HIV-
positive individuals may live into old age.
ACKNOWLEDGEMENTS
This study is dedicated to the memory of Ettore MS Conti. This
work was supported by the Istituto Superiore di Sanita `, Rome,
Grant No. 20D/1.1 and has received additional funding from
Ministry of Health FSN 2002 Grant No. 122. We thank Dr Giorgio
Luppi (Emilia Romagna statistical office) for providing the
distribution of some Cancer Registry populations and Mrs Luigina
Mei for editorial assistance.
REFERENCES
Ajdaicic-Gross V, Zellweger U, Wang J, Fleerackers Y, Somaini B (2001)
How complete is AIDS surveillance in Europe? An eagle eye comparison
with mortality data. J Epidemiol Commun Health 55: 52–56
Ascoli V, Belli S, Benedetti M, Trinca S, Ricci P, Comba P (2001) High
incidence of classic Kaposi’s sarcoma in Mantua, Po Valley, Northern
Italy (1989–1998). Br J Cancer 85: 379–382
Ascoli V, Zambon P, Manno D, Guzzinati S, Zorzi M, Arca B, Costantini C,
Coluzzi M (2003) Variability in the incidence of classic Kaposi’s sarcoma
in the Veneto region, Northern Italy. Tumori 89: 122–124
Atzori L, Fadda D, Ferrelli C, Pastorelli C, Iannelli P, Rais M, Faa G, Cocco
P, Aste N (2004) Classical Kaposi’s sarcoma in southern Sardinia, Italy.
Br J Cancer 91: 1261–1262
Breslow NE, Day NE (1987) Statistical Methods in Cancer Research. Vol II.
The Design and Analysis of Cohort Studies IARC Sci Publ No. 82. IARC:
Lyon
Calabro ` ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E,
Angarano G, Chieco-Bianchi L, Schulz TF (1998) Seroprevalence of
Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 in several
regions of Italy. J Hum Virol 1: 207–213
Coluzzi M, Calabro ` ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V
(2003) Reduced seroprevalence of Kaposi’s sarcoma-associated herpes-
virus (KSHV), human herpesvirus 8 (HHV8), related to suppression of
Anopheles density in Italy. Med Vet Entomol 17: 1–4
Cottoni F, De Marco R, Montesu MA (1996) Classical Kaposi’s sarcoma in
north-east Sardinia: an overview from 1977 to 1991. Br J Cancer 72:
1132–1133
Dal Maso L, Braga C, Franceschi S (2001a) Methodology used for ‘Software
for Automated Linkage in Italy’ (SALI). J Biomed Informatics 34: 387–395
Dal Maso L, Franceschi S, Lo Re A, La Vecchia C (1999) Comparison of the
distribution of non-AIDS Kaposi’s sarcoma and non-Hodgkin’s lym-
phoma in Europe. Br J Cancer 79: 161–163
Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, Falcini F,
Guzzinati S, Zanetti R, Vercelli M, Rezza G, Cancer and AIDS Registry
Linkage Study (2003) Risk of cancer in persons with AIDS in Italy, 1985–
1998. Br J Cancer 89: 94–100
Dal Maso L, Serraino D, Franceschi S (2001b) Epidemiology of AIDS-
related tumours in developed and developing countries. Eur J Cancer 37:
1188–1201
Dictor M, Attewell R (1988) Epidemiology of Kaposi’s sarcoma in Sweden
prior to the acquired immunodeficiency syndrome. Int J Cancer 42:
346–351
Franceschi S, Dal Maso L, Pezzotti P, Polesel J, Braga C, Piselli P, Serraino
D, Tagliabue G, Federico M, Ferretti S, De Lisi V, La Rosa F, Conti E,
Budroni M, Vicario G, Piffer S, Pannelli F, Giacomin A, Bellu ` F, Tumino
R, Fusco M, Rezza G, Cancer and AIDS Registry Linkage Study (2003)
Incidence of AIDS-defining cancers after AIDS diagnosis among people
with AIDS in Italy, 1986–1998. J Acquir Immune Defic Syndr 34: 84–90
Franceschi S, Geddes M (1995) Epidemiology of classic Kaposi’s sarcoma,
with special reference to Mediterranean population. Tumori 81: 308–314
Geddes M, Franceschi S, Balzi D, Arniani S, Gafa ` L, Zanetti R (1995)
Birthplace and classic Kaposi’s sarcoma in Italy. J Natl Cancer Inst 87:
1015–1017
Geddes M, Franceschi S, Barchielli A, Falcini F, Carli S, Cocconi G, Conti E,
Crosignani P, Gafa ` L, Giarelli L, Vercelli M, Zanetti R (1994) Kaposi’s
sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69:
333–336
Classic Kaposi’s sarcoma in Italy
L Dal Maso et al
192
British Journal of Cancer (2005) 92(1), 188–193 & 2005 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yGuttman-Yassky E, Bar-Chana M, Yukelson A, Linn S, Friedman-Birnbaum
R, Bergman R, Sarid R, Silbermann M (2003) Epidemiology of classic
Kaposi’s sarcoma in the Israeli Jewish population between 1960 and
1998. Br J Cancer 89: 1657–1660
Hjalgrim H, Tulinius H, Dalberg J, Hardarson S, Frisch M, Melbye M (1998)
High incidence of classical Kaposi’s sarcoma in Iceland and the Faroe
Islands. Br J Cancer 77: 1190–1193
International Agency for Research on Cancer Working Group on the
Evaluation of Carcinogenic Risks to Humans (1996) Human immuno-
deficiency viruses and human T-cell lymphotropic viruses. IARC Monogr
Eval Carcinog Risks Hum, Vol 67. IARC: Lyon
Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R (2000) Classic Kaposi
sarcoma. Epidemiology and risk factors. Int J Cancer 88: 500–517
Istituto Superiore di Sanita ` (2003) Aggiornamento dei casi di AIDS
notificati in Italia al 30 giugno 2003. Notiziario ISS 16(Suppl 1): 1–15.
Available at: http://www.iss.it/publ/noti/2003/03s3/03s3.pdf.
Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ
(2003) Human herpesvirus 8 infection within families in rural Tanzania.
J Infect Dis 187: 1780–1785
Moore PS, Chang Y (1998) Kaposi’s sarcoma (KS) KS-associated
herpesvirus, and the criteria for causality in the age of molecular
biology. Am J Epidemiol 147: 217–221
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (eds) (1992)
Cancer Incidence in Five Continents. IARC Sci Publ No. 120, Vol VI.
IARC: Lyon
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer
Incidence in Five Continents. IARC Sci Publ No. 143, Vol VII. IARC: Lyon
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer
Incidence in Five Continents. IARC Sci Publ No. 155, Vol. VIII. IARC: Lyon
Perna AM, Bonura F, Vitale F, Viviano E, Di Benedetto MA, Ajello F,
Villafrate MR, Prestileo T, Mancuso S, Goedert JJ, Romano N (2000)
Antibodies to human herpes virus type 8 (HHV8) in general population
and in individuals at risk for sexually transmitted diseases in Western
Sicily. Int J Epidemiol 29: 175–179
Santarelli R, De Marco R, Masala MV, Angeloni A, Uccini S, Pacchiarotti R,
Montesu MA, Satta R, Cerimele D, Faggioni A, Cottoni F (2001) Direct
correlation between human herpesvirus-8 seroprevalence and classic
Kaposi’s sarcoma incidence in Northern Sardinia. J Med Virol 65:
368–372
Serraino D, Locatelli M, Songini M, Cirillo R, Bottazzo GF, Andreoni M,
Franceschi S, Rezza S, Sardinia-Newborn Study Group (2001) Human
herpes virus-8 infection among pregnant women and their children:
results from the Sardinia-IDDM Study 2. Int J Cancer 91: 740–741
Whitby D, Boshoff C (1998) Kaposi’s sarcoma herpesvirus as a new
paradigm for virus-induced oncongenesis. Curr Opin Oncol 10: 405–412
Whitby D, Luppi M, Barozzi P, Boshoff P, Weiss RA, Torelli G (1998)
Human herpesvirus 8 seroprevalence in blood donors and lymphoma
patients from different regions of Italy. J Natl Cancer Inst 90: 395–397
Wojcicki JM (2003) Traditional behavioural practices, the exchange of
saliva and HHV-8 transmission in sub-Saharan African populations. Br J
Cancer 89: 2016–2017
Zanetti R, Gafa ` L, Pannelli F, Conti E, Rosso S (eds) (2002) Cancer in Italy
Incidence Data From Cancer Registries Vol 3, 1993–1998. Il Pensiero
Scientifico Editore: Roma
Appendix
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di Sassari); Carmela Nicita (Registro Tumori Ragusa); Paolo
Contiero (Registro Tumori Lombardia – Provincia di Varese);
Stefano Rosso (Registro Tumori Piemonte, Torino); Maria Elisa
Artioli (Registro Tumori della Provincia di Modena); Maria
Antonietta Orengo (Registro Tumori Ligure, Genova); Pier Carlo
Vercellino (Registro Tumori della Provincia di Biella); Loris Zanier
(Registro Tumori del Friuli-Venezia Giulia); Fabio Vittadello
(Registro Tumori dell’Alto Adige); Rosa Vattiato (Registro Tumori
della Romagna, Forlı `); Carmen Fiorella Stocco (Registro Tumori
del Veneto, Padova); Eugenio Paci (Registro Tumori Toscano,
Firenze); Lidia Serventi (Registro Tumori della Provincia di
Parma); Franco Pannelli (Registro Tumori Provincia di Macerata,
Camerino); Maria Gentilini (Registro Tumori della Provincia di
Trento); Francesco La Rosa (Registro Tumori Umbro); Valerio
Ramazzotti, Maurilio Natali (Registro Tumori di Popolazione della
Provincia di Latina); Mario Fusco, Maurizio Montella (Registro
Tumori della Provincia di Napoli); Stefano Boros (Istituto Super-
iore di Sanita `, Roma)
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